Wednesday, October 14, 2026

HomeHealth NewsRAD51 testing shows promise in personalized early breast cancer treatment

RAD51 testing shows promise in personalized early breast cancer treatment

- Advertisement -

Credit: Anna Tarazevich from Pexels

Published in Clinical Cancer Research, results of a VHIO-led study underscore the potential of the RAD51 biomarker in tailoring treatment strategies in patients with early breast cancer.

…

Click here to view the original article.

- Advertisment -
- Advertisement -

Recently Viewed